For the initial evaluation of low-risk patients with stable chest pain, anatomic testing—coronary CT angiography (CTA) with or without noninvasive fractional flow reserve (FFR)—is cost-effective ...

Part 1 addressed possible explanations for the negative findings of the GRAVITAS trial and the implications for current clinical practice. In Part 2, the story continues with a discussion of the ...